Targeting `Undruggable' Cancer Proteins with Irreversible Small Molecule Inhibitors: Her3 and KRas
With the lighting speed revolution of technologies in chemistry and biology, increasing number of proteins which eluded scientists' efforts to block them before and were labeled as `undruggable', were successfully targeted with small molecule inhibitors. During the past five years, I have...
Main Author: | |
---|---|
Other Authors: | |
Language: | en_US |
Published: |
Harvard University
2014
|
Subjects: | |
Online Access: | http://dissertations.umi.com/gsas.harvard:11384 http://nrs.harvard.edu/urn-3:HUL.InstRepos:12274197 |